Cite
Apfel V, Begue D, Cordo' V, et al. Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms. ACS Pharmacol Transl Sci. 2021;4(1):327-337doi: 10.1021/acsptsci.0c00196.
Apfel, V., Begue, D., Cordo', V., Holzer, L., Martinuzzi, L., Buhles, A., Kerr, G., Barbosa, I., Naumann, U., Piquet, M., Ruddy, D., Weiss, A., Ferretti, S., Almeida, R., Bonenfant, D., Tordella, L., & Galli, G. G. (2021). Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms. ACS pharmacology & translational science, 4(1), 327-337. https://doi.org/10.1021/acsptsci.0c00196
Apfel, Verena, et al. "Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms." ACS pharmacology & translational science vol. 4,1 (2021): 327-337. doi: https://doi.org/10.1021/acsptsci.0c00196
Apfel V, Begue D, Cordo' V, Holzer L, Martinuzzi L, Buhles A, Kerr G, Barbosa I, Naumann U, Piquet M, Ruddy D, Weiss A, Ferretti S, Almeida R, Bonenfant D, Tordella L, Galli GG. Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms. ACS Pharmacol Transl Sci. 2021 Jan 13;4(1):327-337. doi: 10.1021/acsptsci.0c00196. eCollection 2021 Feb 12. PMID: 33615182; PMCID: PMC7887857.
Copy
Download .nbib